Skip to main content

Table 1 CBC counts of Sall4 f/f CreER T2, Sall4 f/f Cre-, and RosaCreERT2 control animals 14 days after TAM treatment (n ≥ 3 for each group). Blood counts were obtained with a Hemavet950 cell counter

From: The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis

Group

WBC

RBC

NEUT

LYMPH

MONO

HCT

Sall4 f/f CreER

8.3 ± 1.8

9.4 ± 0.2

9.7 ± 0.4

85.6 ± 0.4

1.3 ± 0.1

46.7 ± 1.2

Sall4 f/f Cre-

10.0 ± 0.4

9.9 ± 0.2

10.8 ± 0.8

84.2 ± 0.7

1.3 ± 0.2

51.1 ± 1.4

RosaCreER

6.0 ± 0.6

9.6 ± 0.4

9.1 ± 0.6

82.8 ± 0.6

3.5 ± 0.9

50.6 ± 2.0

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us